Democratic Republic of the Congo - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Democratic Republic of the Congo Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 16.8% year on year. With 960 Cases in 2019, the country was number 47 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Democratic Republic of the Congo is overtaken by Mozambique, which was number 46 with 976 Cases and is followed by Tajikistan at 944 Cases. India ranked the highest with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 960.00 |
2018 | 898.00 |
2017 | 893.00 |
2016 | 709.00 |
2015 | 499.00 |
How does Democratic Republic of the Congo rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
42 |
#42
Azerbaijan
|
1,063 | 2019 | +2.4 % | +1.1 % | View data | |
47 |
#47
Democratic Republic of the Congo
|
960 | 2019 | +6.9 % | +16.8 % | View data | |
48 |
#48
Tajikistan
|
944 | 2019 | +3.1 % | +0.9 % | View data |